US Patent 7914817 Treatment of inflammatory bowel disease
All edits
Edits on 27 Nov, 2023
Golden AI
Edits made to:
Article (+379 characters)
Article
Patent abstract
Patients suffering from inflammatory bowel disease such as Crohn's disease or ulcerative colitis are treated either orally or intravenously with methylol transfer agents, such as taurolidine and/or taurultam. These agents can be used in combination with other drugs thereby allowing the use of smaller amounts of the other drugs and limiting unwanted side effects.
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07914817 Treatment of inflammatory bowel disease US Patent 7914817 Treatment of inflammatory bowel disease
Infobox
Patent Number
0791481700
Patent Number
791481700
Edits on 6 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
079148170
Date of Patent
March 29, 2011
0Patent Application Number
110399580
Date Filed
January 24, 2005
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
079148170
Date of Patent
March 29, 2011
0Patent Application Number
110399580
Date Filed
January 24, 2005
0Official Website
Patent Primary Examiner
Edits on 19 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 7 Dec, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07914817 Treatment of inflammatory bowel disease
Infobox
Is a
Patent jurisdiction
Patent number
07914817
Date of patent
March 29, 2011
Patent application number
11039958
Date Filed
January 24, 2005
Patent primary examiner
Find more entities like US Patent 7914817 Treatment of inflammatory bowel disease
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
